跳至主要内容
临床试验/NCT03582267
NCT03582267已完成不适用

The Effect of Docosahexaenoic Acid Supplementation on Biomarkers of Concussion Over the Course of a Year in Canadian National Rugby Players

Texas Christian University2 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2017年8月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
50
试验地点
2
主要终点
Blood concentration of neurofilament light protein

研究概览

简要总结

Nutrition interventions may present a safe and relatively risk free intervention for protection against subconcussive impacts. Docosahexaenoic acid (DHA, 22:6n-3) is the principal Omega 3 polyunsaturated fatty acid in the brain, playing an integral role in the brain's development and structural integrity. The goal of this study is to determine if supplementation with DHA attenuates blood biomarkers of repetitive head trauma linked to sub-concussive impacts sustained in rugby participation.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • Canadian national rugby athletes on 7s and 15s teams

排除标准

  • 未提供

研究组 & 干预措施

Dietary Supplement

Experimental

Docosahexaenoic Acid (DHA)

干预措施: Docosahexaenoic Acid (DHA) (Dietary Supplement)

No Intervention

No Intervention

No Docosahexaenoic Acid supplementation

结局指标

主要结局

Blood concentration of neurofilament light protein

时间窗: 12 times throughout course of 1 year

Concentrations of neuronally derived proteins measured in blood

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jonathan Oliver

Assistant Professor

Texas Christian University

研究点 (2)

Loading locations...

相似试验